Philadelphia Pharmaceuticals Company (ASE: PHIL)
Health Care · Pharmaceuticals · JO
JD1.84
-7.07% today · +24.3% 1Y
Philadelphia Pharmaceuticals Company (ASE: PHIL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $19.47M.
Over the last twelve months the share price has gained 24.3%, trading between 1.48 and 2.01.
Tweenvest scores Philadelphia Pharmaceuticals Company across four factors: quality 78/100, value 27/100, growth 50/100, dividend 90/100. Its strongest factor is dividend.
PHIL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.47M
- Revenue (TTM)
- $12.65M
- P/E
- 13.02
- EPS
- 0.14
- Dividend yield
- —
- Beta (5Y)
- -0.03
- 52-week high
- JD2.01
- 52-week low
- JD1.48
- Avg volume (3M)
- —
- Shares outstanding
- 7.50M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,244.86 | -0.17% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.41 | -0.96% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.93 | +0.18% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.90 | +0.13% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.99 | +0.07% |
Figures last refreshed Aug 18, 2026.